Short Interest in Coloplast A/S (OTCMKTS:CLPBY) Increases By 264.4%

Coloplast A/S (OTCMKTS:CLPBY) was the recipient of a significant increase in short interest in the month of March. As of March 15th, there was short interest totalling 280,600 shares, an increase of 264.4% from the February 28th total of 77,000 shares. Based on an average trading volume of 482,700 shares, the days-to-cover ratio is currently 0.6 days.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on the stock. Royal Bank of Canada upgraded shares of Coloplast A/S from a “hold” rating to a “moderate buy” rating in a report on Monday, March 3rd. Sanford C. Bernstein raised Coloplast A/S from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, January 28th. Finally, UBS Group upgraded Coloplast A/S from a “strong sell” rating to a “hold” rating in a report on Wednesday, December 11th.

Coloplast A/S Stock Performance

OTCMKTS CLPBY opened at $10.52 on Friday. The company has a 50 day moving average of $10.99 and a 200-day moving average of $11.90. The company has a quick ratio of 0.66, a current ratio of 1.02 and a debt-to-equity ratio of 0.92. Coloplast A/S has a 1-year low of $10.31 and a 1-year high of $14.14.

Coloplast A/S (OTCMKTS:CLPBY) last posted its quarterly earnings results on Tuesday, February 4th. The company reported $0.07 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.08 by ($0.01). Coloplast A/S had a return on equity of 28.60% and a net margin of 17.81%. As a group, analysts expect that Coloplast A/S will post 0.31 earnings per share for the current year.

About Coloplast A/S

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments.